Oncolytics: Cancer Virotherapy - Risky but Astronomical Upside

Hi tp100

-re ONCY + are we expecting much soon?
-well, there are a number of items, and using 'soon' in its biotech form, for me, means this half year, we should see results from the phase I Canadian glio trials, should be this quarter in fact.

-then there are the phase 1 results from marsden monotherapy, phase 1 results from Combo therapy and phase 1 results from US systemic.

-Marsden is probably the most important of these, although the Combo trial is not far behind, imo. Think the indication was for second quarter results from Marsden, with the others around that sort of time as well.

-Then we should have news of the phase 2 plans, always assuming the phase 1 results merit that.....and from the interim marsden results, that looks highly likely

-And I guess we could always get news of the start of the US glio trials and the long-awaited NCI trials.....there has been quite a wait for these already, but with the other trials underway, perhaps not too much of a big deal.

-I think ONCY should make great strides this year....they didn't do too badly last year, butI expect and hope that progress with trials will be reflected with a strongly rising share price.

OT: Re Corac, feel very bullish on these, fwiw.Probably a year to early with these last year, but brings taper relief that much nearer, if I make a profit!!!